2020, 1, ISBN 0367187779, Volume 1, 246
This book explains cooperative and confrontational regional orders in the post-Cold War era. Applying a push-and-pull framework to the evolution of regional...
International Relations | International Organizations | International Security | Security Studies - Pol & Intl Relns | Regionalism | Regionalism-South America | Security, International-Eurasia | Regionalism (International organization) | Regionalism-Eurasia | World politics-1989 | Interregionalism | Security, International-South America
International Relations | International Organizations | International Security | Security Studies - Pol & Intl Relns | Regionalism | Regionalism-South America | Security, International-Eurasia | Regionalism (International organization) | Regionalism-Eurasia | World politics-1989 | Interregionalism | Security, International-South America
eBook
2000, ISBN 9819451015, 594
Book
3.
El fogón de la memoria
: historias de vida y de luchas de los 70 hasta hoy, rupturas y continuidades
2007, ISBN 9789872351434, 223
Book
1997, Cuadernos de historia del derecho, ISBN 9789875070189, Volume 10, 652
Book
1992, Serie Mayor, ISBN 9504333397, Volume 1, 511
Book
1988, Cuadernos de investigaciones, Volume 5, 92
Book
Journal of Environmental Management, ISSN 0301-4797, 07/2018, Volume 217, pp. 969 - 979
We analyse incentives, equilibria and implications of the governance framework for the disposal of municipal solid waste in an -Region model where waste...
Waste management | Decentralisation | Waste mobility | Environmental quality | Welfare | SPILLOVERS | ENVIRONMENTAL SCIENCES | FISCAL FEDERALISM | Analysis | Transfer pricing
Waste management | Decentralisation | Waste mobility | Environmental quality | Welfare | SPILLOVERS | ENVIRONMENTAL SCIENCES | FISCAL FEDERALISM | Analysis | Transfer pricing
Journal Article
SpringerPlus, ISSN 2193-1801, 12/2016, Volume 5, Issue 1, pp. 1 - 23
Traditional fiscal federalism theory postulates that devolution for the provision of local public goods increases welfare. However, most of the services...
Grants-in-aid | H72 | H71 | Devolution | Science | Spillovers | Impure public goods | Science, general | OECD | FISCAL FEDERALISM | MULTIDISCIPLINARY SCIENCES
Grants-in-aid | H72 | H71 | Devolution | Science | Spillovers | Impure public goods | Science, general | OECD | FISCAL FEDERALISM | MULTIDISCIPLINARY SCIENCES
Journal Article
Social Science & Medicine, ISSN 0277-9536, 02/2014, Volume 102, pp. 69 - 73
Drug price regulation is acquiring increasing significance in the investment choices of the pharmaceutical sector. The overall objective is to determine an...
Price regulation | Value based pricing | Pharmaceutical industry | Listing process | Welfare analysis | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-SHARING AGREEMENTS | SOCIAL SCIENCES, BIOMEDICAL | INNOVATION | Pharmaceutical Preparations - economics | Economics, Pharmaceutical | Costs and Cost Analysis | Social Welfare - economics | Drug Industry - economics | Humans | Cost Control | Italy | Analysis | Pricing | Drugs | Prices | Consumer protection | Welfare
Price regulation | Value based pricing | Pharmaceutical industry | Listing process | Welfare analysis | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-SHARING AGREEMENTS | SOCIAL SCIENCES, BIOMEDICAL | INNOVATION | Pharmaceutical Preparations - economics | Economics, Pharmaceutical | Costs and Cost Analysis | Social Welfare - economics | Drug Industry - economics | Humans | Cost Control | Italy | Analysis | Pricing | Drugs | Prices | Consumer protection | Welfare
Journal Article
1990, ISBN 9509951412, 346
Book
2002, Historia de la sociedad política, ISBN 9788425911804, 333
Book
International Journal of Health Economics and Management, ISSN 2199-9023, 6/2017, Volume 17, Issue 2, pp. 235 - 249
We study the welfare properties of direct restrictions based on cost-effectiveness and indirect methods represented by waiting lists in a public health care...
Health Economics | Economic Policy | Public Health | Health Administration | Public Finance | H51 | I11 | Health Care Management | I18 | Redistribution | Medicine & Public Health | Welfare analysis | Waiting lists | Explicit restrictions | BUSINESS, FINANCE | WAITING-LISTS | COST-EFFECTIVENESS | HEALTH POLICY & SERVICES | TIME | ECONOMICS | Rationing | Analysis | Public health | Health care reform | Health care | Studies | Lists | Welfare | Income | Constrictions | Casts
Health Economics | Economic Policy | Public Health | Health Administration | Public Finance | H51 | I11 | Health Care Management | I18 | Redistribution | Medicine & Public Health | Welfare analysis | Waiting lists | Explicit restrictions | BUSINESS, FINANCE | WAITING-LISTS | COST-EFFECTIVENESS | HEALTH POLICY & SERVICES | TIME | ECONOMICS | Rationing | Analysis | Public health | Health care reform | Health care | Studies | Lists | Welfare | Income | Constrictions | Casts
Journal Article
Annals of Public and Cooperative Economics, ISSN 1370-4788, 12/2017, Volume 88, Issue 4, pp. 471 - 498
ABSTRACT In this study, we analyze the regulation of markets for the provision of services whose costs are subsidized for paternalistic reasons. We model the...
Monopoly franchise | D47 | H44 | L51 | Quality competition | Spatial competition | Paternalistic goods | Semi‐altruistic providers | Semi-altruistic providers | Monopolies | Laws, regulations and rules | Analysis | Franchises | Economic models | Regulation | Altruism | Profit maximization
Monopoly franchise | D47 | H44 | L51 | Quality competition | Spatial competition | Paternalistic goods | Semi‐altruistic providers | Semi-altruistic providers | Monopolies | Laws, regulations and rules | Analysis | Franchises | Economic models | Regulation | Altruism | Profit maximization
Journal Article
Health Economics, ISSN 1057-9230, 01/2011, Volume 20, Issue 1, pp. 101 - 110
In this note we explore the welfare properties of access restrictions to health care based on cost effectiveness. We show that such instrument can improve the...
welfare analysis | cost effectiveness | HEALTH CARE SCIENCES & SERVICES | NICE | HEALTH POLICY & SERVICES | ECONOMICS | EFFECTIVENESS THRESHOLD | Private Sector | Social Welfare | State Medicine | Delivery of Health Care | Public Sector | Cost-Benefit Analysis | Humans | United Kingdom | Models, Statistical | Health Services Accessibility - economics | cost effectiveness; welfare analysis | Studies | Welfare | Health services | Utility functions | Cost reduction | Health care access | Restrictions
welfare analysis | cost effectiveness | HEALTH CARE SCIENCES & SERVICES | NICE | HEALTH POLICY & SERVICES | ECONOMICS | EFFECTIVENESS THRESHOLD | Private Sector | Social Welfare | State Medicine | Delivery of Health Care | Public Sector | Cost-Benefit Analysis | Humans | United Kingdom | Models, Statistical | Health Services Accessibility - economics | cost effectiveness; welfare analysis | Studies | Welfare | Health services | Utility functions | Cost reduction | Health care access | Restrictions
Journal Article
NATURE, ISSN 0028-0836, 03/2012, Volume 483, Issue 7391, pp. 541 - 541
Journal Article
Derecho PUCP, ISSN 0251-3420, 05/2019, Issue 82, pp. 9 - 33
In 1921, the Argentine Republic enacted its second national Criminal Code, which came into force the following year. The work exposes and glosses the comments...
Argentina | diario La Nación | periódico jurídico | Código Penal | periódico general
Argentina | diario La Nación | periódico jurídico | Código Penal | periódico general
Journal Article
1992, Serie V centenario del descubrimiento de América, 379
Book
Derecho PUCP, ISSN 0251-3420, 2019, Issue 82, pp. 9 - 33
Journal Article
JAMA, ISSN 0098-7484, 07/2011, Volume 306, Issue 3, pp. 269 - 276
CONTEXT Premenopausal patients with breast cancer are at high risk of premature ovarian failure induced by systemic treatments, but no standard strategies for...
ADJUVANT CHEMOTHERAPY | INDUCED GONADOTOXICITY | OVARIAN SUPPRESSION | AMENORRHEA | MEDICINE, GENERAL & INTERNAL | CYCLOPHOSPHAMIDE | GOSERELIN | YOUNG-WOMEN | CARCINOMA | FERTILITY | AGE | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Premenopause | Humans | Middle Aged | Injections, Intramuscular | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Cisplatin - administration & dosage | Primary Ovarian Insufficiency - chemically induced | Fluorouracil - administration & dosage | Luteolytic Agents - therapeutic use | Menopause - drug effects | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - adverse effects | Neoadjuvant Therapy - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Adult | Female | Infertility, Female - prevention & control | Methotrexate - administration & dosage | Primary Ovarian Insufficiency - prevention & control | Goserelin - therapeutic use | Breast cancer | Drug therapy | Womens health | Menopause | Risk factors
ADJUVANT CHEMOTHERAPY | INDUCED GONADOTOXICITY | OVARIAN SUPPRESSION | AMENORRHEA | MEDICINE, GENERAL & INTERNAL | CYCLOPHOSPHAMIDE | GOSERELIN | YOUNG-WOMEN | CARCINOMA | FERTILITY | AGE | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Premenopause | Humans | Middle Aged | Injections, Intramuscular | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Cisplatin - administration & dosage | Primary Ovarian Insufficiency - chemically induced | Fluorouracil - administration & dosage | Luteolytic Agents - therapeutic use | Menopause - drug effects | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - adverse effects | Neoadjuvant Therapy - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Adult | Female | Infertility, Female - prevention & control | Methotrexate - administration & dosage | Primary Ovarian Insufficiency - prevention & control | Goserelin - therapeutic use | Breast cancer | Drug therapy | Womens health | Menopause | Risk factors
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 24, pp. 2632 - 2640
IMPORTANCE: Whether the administration of luteinizing hormone–releasing hormone analogues (LHRHa) during chemotherapy is a reliable strategy to preserve...
MEDICINE, GENERAL & INTERNAL | FERTILITY PRESERVATION | CYCLOPHOSPHAMIDE | HORMONE AGONISTS | TAMOXIFEN | DOXORUBICIN | CONSENSUS | ANTAGONISM | OUTCOMES | YOUNG-WOMEN | PREMENOPAUSAL PATIENTS | Follow-Up Studies | Humans | Middle Aged | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - physiopathology | Recovery of Function | Pregnancy | Disease-Free Survival | Breast Neoplasms - chemistry | Premenopause - drug effects | Drug Interactions | Luteolytic Agents - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Antineoplastic Agents, Hormonal - therapeutic use | Ovary - secretion | Adult | Breast Neoplasms - mortality | Female | Ovary - drug effects | Menstrual Cycle - physiology | Pregnancy Rate | Clinical trials | Usage | Care and treatment | Breast cancer | Adjuvant treatment | Cancer | Reproductive health | Chemotherapy | Womens health | Clinical outcomes
MEDICINE, GENERAL & INTERNAL | FERTILITY PRESERVATION | CYCLOPHOSPHAMIDE | HORMONE AGONISTS | TAMOXIFEN | DOXORUBICIN | CONSENSUS | ANTAGONISM | OUTCOMES | YOUNG-WOMEN | PREMENOPAUSAL PATIENTS | Follow-Up Studies | Humans | Middle Aged | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - physiopathology | Recovery of Function | Pregnancy | Disease-Free Survival | Breast Neoplasms - chemistry | Premenopause - drug effects | Drug Interactions | Luteolytic Agents - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Antineoplastic Agents, Hormonal - therapeutic use | Ovary - secretion | Adult | Breast Neoplasms - mortality | Female | Ovary - drug effects | Menstrual Cycle - physiology | Pregnancy Rate | Clinical trials | Usage | Care and treatment | Breast cancer | Adjuvant treatment | Cancer | Reproductive health | Chemotherapy | Womens health | Clinical outcomes
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.